Page last updated: 2024-10-20

pyrazole and Helicobacter Infections

pyrazole has been researched along with Helicobacter Infections in 1 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research Excerpts

ExcerptRelevanceReference
"Pyrazole was found to be a competitive inhibitor of HpSCADH."1.39A short chain NAD(H)-dependent alcohol dehydrogenase (HpSCADH) from Helicobacter pylori: a role in growth under neutral and acidic conditions. ( Alka, K; Cornally, D; Henehan, GT; Ryan, BJ; Windle, HJ, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alka, K1
Windle, HJ1
Cornally, D1
Ryan, BJ1
Henehan, GT1

Other Studies

1 other study available for pyrazole and Helicobacter Infections

ArticleYear
A short chain NAD(H)-dependent alcohol dehydrogenase (HpSCADH) from Helicobacter pylori: a role in growth under neutral and acidic conditions.
    The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:7

    Topics: Alcohol Oxidoreductases; Amino Acid Sequence; Gastric Mucosa; Helicobacter Infections; Helicobacter

2013